Medfield Diagnostics AB (publ)

NGM:MEDF Stock Report

Market Cap: SEK 23.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Medfield Diagnostics Balance Sheet Health

Financial Health criteria checks 4/6

Medfield Diagnostics has a total shareholder equity of SEK73.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK77.0M and SEK3.2M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 7.11m
EquitySEK 73.77m
Total liabilitiesSEK 3.23m
Total assetsSEK 77.01m

Recent financial health updates

Recent updates

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

May 12
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Dec 29
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Sep 07
Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Financial Position Analysis

Short Term Liabilities: MEDF's short term assets (SEK11.9M) exceed its short term liabilities (SEK3.2M).

Long Term Liabilities: MEDF has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: MEDF is debt free.

Reducing Debt: MEDF had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MEDF has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: MEDF has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.9% each year


Discover healthy companies